References

10.1016/s0140-6736(20)30183-5

10.1016/s0140-6736(20)30183-5 · External reference

10.1097/cm9.0000000000000744

10.1097/cm9.0000000000000744 · External reference

10.1136/bmj.m606

10.1136/bmj.m606 · External reference

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

2020 · External reference

Unresolved reference

External reference

10.1016/j.ijid.2020.03.017

10.1016/j.ijid.2020.03.017 · External reference

10.1016/j.jstrokecerebrovasdis.2020.104949

10.1016/j.jstrokecerebrovasdis.2020.104949 · External reference

Unresolved reference

External reference

10.1183/13993003.01148-2020

10.1183/13993003.01148-2020 · External reference

10.1016/s0140-6736(20)30566-3

10.1016/s0140-6736(20)30566-3 · External reference

Unresolved reference

External reference

10.18632/aging.103000

10.18632/aging.103000 · External reference

10.1016/j.jinf.2020.03.005

10.1016/j.jinf.2020.03.005 · External reference

10.14336/ad.2020.0502

10.14336/ad.2020.0502 · External reference

10.1038/s41440-020-0485-2

10.1038/s41440-020-0485-2 · External reference

10.1161/circresaha.120.317242

10.1161/circresaha.120.317242 · External reference

Unresolved reference

External reference

10.1590/s1678-9946202062043

10.1590/s1678-9946202062043 · External reference

10.1016/j.ajic.2020.06.213

10.1016/j.ajic.2020.06.213 · External reference

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

10.1371/journal.pone.0238215 · 2020 · External reference

10.15585/mmwr.mm6915e3

10.15585/mmwr.mm6915e3 · External reference

Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life

10.1161/hypertensionaha.107.095380 · 2007 · External reference

10.1161/01.hyp.0000252676.46043.18

10.1161/01.hyp.0000252676.46043.18 · External reference

10.1152/ajpcell.00145.2008

10.1152/ajpcell.00145.2008 · External reference

10.1152/ajpheart.00061.2006

10.1152/ajpheart.00061.2006 · External reference

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

10.1161/circulationaha.104.510461 · 2005 · External reference

10.1002/path.5471

10.1002/path.5471 · External reference

10.1016/j.cell.2020.02.052

10.1016/j.cell.2020.02.052 · External reference

10.1126/science.abb2507

10.1126/science.abb2507 · External reference

10.3389/fped.2020.00206

10.3389/fped.2020.00206 · External reference

Recombinant human ACE2: acing out angiotensin II in ARDS therapy

10.1186/s13054-017-1882-z · 2017 · External reference

10.1080/22221751.2020.1746200

10.1080/22221751.2020.1746200 · External reference

10.1016/j.jacc.2020.03.031

10.1016/j.jacc.2020.03.031 · External reference

10.1080/07853890.2020.1790643

10.1080/07853890.2020.1790643 · External reference

SARS-CoV-2: virus dynamics and host response

10.1016/s1473-3099(20)30235-8 · 2020 · External reference

COVID-19 and older adults: What we know

10.1111/jgs.16472 · 2020 · External reference

10.1111/j.1432-2277.2009.00927.x

10.1111/j.1432-2277.2009.00927.x · External reference

Naive T cells in the elderly: are they still there?

10.1196/annals.1354.018 · 2006 · External reference

10.3389/fimmu.2020.00827

10.3389/fimmu.2020.00827 · External reference

Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression

10.1007/s40200-021-00777-4 · 2021 · External reference

Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection

2019 · External reference

10.1016/j.numecd.2021.02.020

10.1016/j.numecd.2021.02.020 · External reference

Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study

10.1016/j.diabet.2020.10.001 · 2021 · External reference